2.92 per cent, due to the decrease of sales. 2. Selling expenses In Q1/2019, the Company incurred selling expenses of Baht 4.97 million, going down year-on-year by Baht 4.23 million or 45.96 per cent

ratio of Admin. Expense over total income for Quarter 1/ 2019 and Quarter 1/2018 were 14.35% and 16.37% respectively, 2% down due to higher income. Income tax expense After You Pcl . 1319/9 Pattanakarn Rd

of the total liabilities. The main non-current liabilities in long-term debt. The long-term debt due date within one year is THB 10.5 MB and THB 8.1 MB respectively, equivalent to 2.4% and 2.2

446 million increased by 24% compared 3 to the same period in the previous year, due to the Company plans to develop salesman and products. Gross margin in Q1/2019 from distributor of medical devices

/2019 held on July 10, 2019 has approved the Company to purchase more shares of the WPS (Thailand) Co., Ltd. (“WPS”) in the proportion of 15% due to the existing shareholders offer to sell their own

June 30, 2018 and the six-month period ended June 30, 2019, respectively. The figures represent a period-on-period increase of 81.31% due mainly to an increasing in number of patients as a result of a

for 2018 in amount of 18.5 million baht in May 2019. Trade and other payables decreased 8.4 million baht and long-term loans due within one year decreased 0.6 million baht. (2.2) Non-Current Liabilities

margin of 36.97%, decreased by 5.03% as a result of the following 2.1 A decrease of gross profit margin by 1.28% due to the practice to comply with Thai Financial Reporting Standard No. 15: Revenue, which

large portion of fixed costs. Some of which increased from the previous year, especially the labor cost and bonus with annual adjustments, and depreciation increasing slightly due to new machines

same period at the previous year. The main reason is due to the increase in marketing and advertising expenses from revamping beauty business under Wuttisak Cosmetic Inter Co., Ltd. 2. Financial